Treatment with angiotensin-converting enzyme inhibitors: insight into perindopril cardiovascular protection [PDF]
Roberto Ferrari
openalex +1 more source
Immune cell uptake of glycinated nanoparticles conjugated to anti-fibrotic peptides enables their prolonged activity and oral administration. [PDF]
Somanader-Livera DVN +9 more
europepmc +1 more source
Antihypertensive drugs for hyperuricemia in patients with hypertension: a systematic review and network meta-analysis of Chinese trials. [PDF]
Wu J, Di H, Zhang Y, Zeng X.
europepmc +1 more source
Risk of liver dysfunction with ACE inhibitors based on real-world data from the MID-NET<sup>®</sup> in Japan. [PDF]
Kinoshita Y +11 more
europepmc +1 more source
Antihypertensive Utility of Perindopril in a Large, General Practice‐Based Clinical Trial [PDF]
Stevo Julius +8 more
openalex +1 more source
Acute Kidney Injury After Accelerated Dosing of Tirzepatide in a Patient with Multiple Comorbidities: A Case Report. [PDF]
Almansour AH.
europepmc +1 more source
Erratum to: Full-dose Perindopril/Indapamide in the Treatment of Difficult-to-Control Hypertension: The FORTISSIMO Study [PDF]
Karpov IuA, Yuri Aleksandrovich Karpov
openalex +1 more source
Angiotensin converting enzyme inhibitors (ACEIs) for anthracycline-induced cardiotoxicity: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Safwan M +3 more
europepmc +1 more source

